Boston Life Sciences says going-concern statement in audit

By Elaine Rigoli

Tampa, Fla., April 7 - Boston Life Sciences, Inc. said the company's report from its independent registered public accounting firm regarding 2005 financial statements contained an explanatory paragraph regarding the company's ability to continue as a going concern.

Nasdaq requires all traded companies to publicly announce if their annual report on form 10-K includes an audit report containing a going-concern statement.

Hopkinton, Mass.-based Boston Life Sciences is engaged in the research and clinical development of diagnostic and therapeutic products for central nervous system disorders.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.